Strategic partnerships CHI collaborates with researchers, clinicians, biotech companies, governmental agencies, and advocacy groups globally, indicating clear partnership channels to leverage for co-branded programs, grant opportunities, and sponsored education initiatives.

Funding potential With annual revenue in the mid-range for nonprofits and a focus on research, opportunities exist for funded programs, donor campaigns, and sponsorships from pharma, biotech, and diagnostic companies seeking patient-centered outreach and awareness in rare disease.

Education and outreach CHI develops educational resources for patients, families, schools, and medical professionals, presenting a readiness for content partnerships, digital education tools, webinars, and multilingual materials to expand reach.

Global awareness Active advocacy and worldwide partnerships position CHI as a gateway to market access initiatives, clinical trial collaborations, and international awareness campaigns that can be monetized through sponsorships and programmatic funding.

Organizational scale Operating with a lean team (11-50 employees) but broad reach suggests high impact opportunities through scalable tech-enabled programs, sponsored conferences, and outsourced service vendors to support growth without high headcount.